225 related articles for article (PubMed ID: 23761674)
1. Regulation of urinary ACE2 in diabetic mice.
Wysocki J; Garcia-Halpin L; Ye M; Maier C; Sowers K; Burns KD; Batlle D
Am J Physiol Renal Physiol; 2013 Aug; 305(4):F600-11. PubMed ID: 23761674
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion.
Chodavarapu H; Grobe N; Somineni HK; Salem ES; Madhu M; Elased KM
PLoS One; 2013; 8(4):e62833. PubMed ID: 23646149
[TBL] [Abstract][Full Text] [Related]
3. Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice.
Somineni HK; Boivin GP; Elased KM
J Endocrinol; 2014 May; 221(2):235-51. PubMed ID: 24756098
[TBL] [Abstract][Full Text] [Related]
4. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
Ye M; Wysocki J; William J; Soler MJ; Cokic I; Batlle D
J Am Soc Nephrol; 2006 Nov; 17(11):3067-75. PubMed ID: 17021266
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.
Yamaleyeva LM; Gilliam-Davis S; Almeida I; Brosnihan KB; Lindsey SH; Chappell MC
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1374-84. PubMed ID: 22378820
[TBL] [Abstract][Full Text] [Related]
6. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition.
Liu CX; Hu Q; Wang Y; Zhang W; Ma ZY; Feng JB; Wang R; Wang XP; Dong B; Gao F; Zhang MX; Zhang Y
Mol Med; 2011; 17(1-2):59-69. PubMed ID: 20844835
[TBL] [Abstract][Full Text] [Related]
9. ACE and ACE2 activity in diabetic mice.
Wysocki J; Ye M; Soler MJ; Gurley SB; Xiao HD; Bernstein KE; Coffman TM; Chen S; Batlle D
Diabetes; 2006 Jul; 55(7):2132-9. PubMed ID: 16804085
[TBL] [Abstract][Full Text] [Related]
10. Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice.
Salem ES; Grobe N; Elased KM
Am J Physiol Renal Physiol; 2014 Mar; 306(6):F629-39. PubMed ID: 24452639
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy.
Batlle D; Wysocki J; Soler MJ; Ranganath K
Kidney Int; 2012 Mar; 81(6):520-8. PubMed ID: 22113528
[TBL] [Abstract][Full Text] [Related]
12. Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy.
Clotet-Freixas S; Soler MJ; Palau V; Anguiano L; Gimeno J; Konvalinka A; Pascual J; Riera M
Lab Invest; 2018 Sep; 98(9):1237-1249. PubMed ID: 29884907
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.
Lin M; Gao P; Zhao T; He L; Li M; Li Y; Shui H; Wu X
Mol Biol Rep; 2016 May; 43(5):397-406. PubMed ID: 26968558
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney.
Pandey A; Goru SK; Kadakol A; Malek V; Gaikwad AB
Biochimie; 2015 Nov; 118():71-81. PubMed ID: 26271886
[TBL] [Abstract][Full Text] [Related]
15. Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.
Gutta S; Grobe N; Kumbaji M; Osman H; Saklayen M; Li G; Elased KM
Am J Physiol Renal Physiol; 2018 Aug; 315(2):F263-F274. PubMed ID: 29561187
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats.
Sharma N; Malek V; Mulay SR; Gaikwad AB
Life Sci; 2019 Oct; 235():116796. PubMed ID: 31470003
[TBL] [Abstract][Full Text] [Related]
17. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.
Chang SY; Chen YW; Chenier I; Tran Sle M; Zhang SL
Exp Diabetes Res; 2011; 2011():521076. PubMed ID: 22110472
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Chinese herbs for stasis removing and collaterals dredging upon angiotensin-converting enzyme 2-angiotensin-(1-7)-mas axis in the renal cortex of diabetic nephropathy rats].
Xu J; Ma EW; Bai L; Ma Y; Guo Q; Jia R; Zhang JH; Chen ZQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):714-21. PubMed ID: 25046956
[TBL] [Abstract][Full Text] [Related]
20. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
